| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/26/2008 | WO2008048124A3 Ssl7 mutants and uses therefor |
| 06/26/2008 | WO2008047242A3 Novel anti-cd38 antibodies for the treatment of cancer |
| 06/26/2008 | WO2008033495A3 Method for detecting and treating skin disorders |
| 06/26/2008 | WO2008005828A3 PHARMACEUTICALLY ACCEPTABLE COMPOSITIONS COMPRISING ANTIBODY MOLECULES SPECIFIC TO LAMININ-5 α3 CHAIN DOMAINS G1G2 AND USE THEREOF |
| 06/26/2008 | WO2007096779A3 Generation of heavy-chain only antibodies in transgenic animals |
| 06/26/2008 | WO2005107801A3 Systems and methods for treating human inflammatory and proliferative diseases, with a combination of fatty acid metabolism inhibitors and glycolytic inhibitors and/or ucp and/or fas antibodies |
| 06/26/2008 | US20080155715 Stress-Responsive Root-Specific Genes |
| 06/26/2008 | US20080154023 Methods and compositions with reduced opalescence |
| 06/26/2008 | US20080154022 Transport of basic fibroblast growth factor across the blood brain barrier |
| 06/26/2008 | US20080153756 Nucleic acids encoding them; for use in modulating alpha 4 integrin function; kits; antibodies against the peptides |
| 06/26/2008 | US20080153751 Albumin Fusion Proteins |
| 06/26/2008 | US20080153747 taipan natriuretic peptide is used for treating congestive heart failure, stimulating vasodilation, natriuresis, diuresis, renin-suppression, bactericidal activity, weight-loss or bone growth; antigen-binding molecule |
| 06/26/2008 | US20080153712 Universal Libraries for Immunoglobulins |
| 06/26/2008 | US20080153159 Therapeutic and diagnostic agents |
| 06/26/2008 | US20080153132 recombinant ecarin protein that specifically activates prothrombin, being efficiently prepared by the genetic engineering technique; ecarin capable of serving conversion from prethrombin-2 to alpha -thrombin or from prothrombin to meizothrombin via cleavage at the Arg-Ile site |
| 06/26/2008 | US20080153112 identification of a predominant ligand of CD8+ T cells that are responsible eq for type 1 diabetes. That ligand is islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP). Several CD8+ T cell-binding peptides from IGRP are identified, including the peptide comprising amino acids |
| 06/26/2008 | US20080153106 Three human endometrial antigens, ME-5, ME-2 and EPP2, and combination thereof have been discovered that are the targets of antibodies present in the serum of women suffering from endometriosis. are used as tools for diagnostic assays these protein products and the human antibodies reactive with them |
| 06/26/2008 | US20080153104 Gene Overexpressed in Cancer |
| 06/26/2008 | US20080153082 Improved stability in high salt concentration solutions, buffers; biosensors; non-nucleotide polyphosphate polymer with a recognition probe conjugated thereto; e.g. polyanion-gold nanoparticle conjugates |
| 06/26/2008 | US20080152673 Comprising histone protein and sugar in form of amorphous solid; plant seed extract effects drying tolerance |
| 06/26/2008 | US20080152653 Heterodimeric integral membrane glycoprotein specific monoclonal antibody for use in treatment of cancer, inflammatory and/or autoimmune disease |
| 06/26/2008 | US20080152651 Beta-like glycoprotein hormone polypeptide specific immunoglobulin for treatment of autoimmune, inflammatory, (such as rheumatoid arthritis, psoriasis, multiple sclerosis, toxic shock, bone marrow and organ transplantation disorders |
| 06/26/2008 | US20080152650 Methods and Compositions For Specifically Targeting Human Hepatocellular Carcinoma Cells |
| 06/26/2008 | US20080152649 Insulin-like growth factor 1 (IGF-1) receptor specific immunogloblin for use in diagnosis, prevention and treatment of cell proliferative |
| 06/26/2008 | US20080152647 Using MG1(mucin) specific immunoglobulins to target therapeutic agents to tumor cells |
| 06/26/2008 | US20080152642 Aiolos, Helios, Daedalos and Ikaros: genes, polypeptides, regulatory elements and uses thereof |
| 06/26/2008 | US20080152631 Cancer Antigen Peptides Derived from Wt1 |
| 06/26/2008 | US20080152620 Hemopoietic cytokine for use in diagnosis, prevention and treatment of skin and respiratory disorders |
| 06/26/2008 | US20080152587 TARGETED BINDING AGENTS DIRECTED TO uPAR AND USES THEREOF |
| 06/26/2008 | US20080152586 Protein complexes comprising three or more polypeptides, each having multiple immunoglobulin like domains, which associate to form target binding regions, for use as therapeutic, diagnostic or imaging agents |
| 06/26/2008 | DE10300335B4 Oxidoreduktase Oxidoreductase |
| 06/26/2008 | CA2839162A1 Methods for the treatment of il-1-.beta. related diseases |
| 06/26/2008 | CA2709411A1 Binding agents to the integrin alpha-11 subunit, and uses thereof |
| 06/26/2008 | CA2698307A1 Histophilus somni antigens, compositions and methods of use |
| 06/26/2008 | CA2675889A1 An activation epitope of fcgammarii (cd32), binding molecules that specifically bind the epitope and means and methods for the detection of epitope, and uses of said epitope or said binding molecules. |
| 06/26/2008 | CA2673331A1 Amino acid sequences directed against gpcrs and polypeptides comprising the same for the treatment of gpcr-related diseases and disorders |
| 06/26/2008 | CA2673222A1 Variants of vegfr and their use in the diagnosis and treatment of pregnancy associated medical conditions |
| 06/26/2008 | CA2672965A1 Amino acid sequences directed against a metalloproteinase from the adam family and polypeptides comprising the same for the treatment of adam-related diseases and disorders |
| 06/26/2008 | CA2672937A1 Inhibitory polynucleotide compositions and methods for treating cancer |
| 06/26/2008 | CA2672770A1 Amino acid sequences directed against fc receptors and polypeptides comprising the same for the treatment of fcr-related diseases and disorders |
| 06/26/2008 | CA2672622A1 Human antibodies to human delta like ligand 4 |
| 06/26/2008 | CA2671538A1 Engineered anti-tslp antibody |
| 06/26/2008 | CA2670992A1 Antagonist anti-notch3 antibodies and their use in the prevention and treatment of notch3-related diseases |
| 06/26/2008 | CA2669921A1 Human monoclonal antibodies to btla and methods of use |
| 06/25/2008 | EP1935991A2 Nucleic acid vaccines for prevention of flavivirus infection |
| 06/25/2008 | EP1935979A2 Antigenic meningococcal peptides |
| 06/25/2008 | EP1935900A1 Peptides derived from colostrinin |
| 06/25/2008 | EP1935899A1 Nucleotide and protein sequence of mammastatin and methods of use |
| 06/25/2008 | EP1935431A2 Cancer treatments by using a combination of an antibody against her2 and interleukin-2 |
| 06/25/2008 | EP1934614A2 Reagents for the detection of protein phosphorylation in carcinoma signaling pathways |
| 06/25/2008 | EP1934363A2 Recurrent gene fusions in prostate cancer |
| 06/25/2008 | EP1934262A1 Antibodies to complementary peptides of thrombin or portions thereof |
| 06/25/2008 | EP1934261A2 Human monoclonal antibodies to cd70 |
| 06/25/2008 | EP1934260A2 Compositions and methods for treating proliferative disorders |
| 06/25/2008 | EP1934259A2 Nanobodies and polypeptides against egfr and igf-ir |
| 06/25/2008 | EP1934258A1 Antibodies against april as biomarkers for early prognosis of lymphoma patients |
| 06/25/2008 | EP1933874A2 Targeted biocides |
| 06/25/2008 | EP1933873A2 Methods and compositions for use in treatment of patients with autoantibody positive diseases |
| 06/25/2008 | EP1933872A2 Anti-glypican-3 antibody |
| 06/25/2008 | EP1933871A2 Human monoclonal antibodies to activin receptor-like kinase-1 |
| 06/25/2008 | EP1933870A2 Treatment of b cell diseases using anti-germline antibody binding agents |
| 06/25/2008 | EP1933864A2 Antibodies as t cell receptor mimics, methods of production and uses thereof |
| 06/25/2008 | EP1861507A4 Optimization of heterologous polypeptide expression |
| 06/25/2008 | EP1667730A4 Compositions and methods for treating inflammatory lung disease |
| 06/25/2008 | EP1616950B1 Peptide having htlv-1-specific ctl-inducing activity |
| 06/25/2008 | EP1418931B1 New angiogenesis inhibitors based on soluble cd44 receptor hyaluronic acid binding domain |
| 06/25/2008 | EP1204752B1 Immunogenic polypeptides derived from moraxella catarrhalis and uses thereof |
| 06/25/2008 | EP1190055B1 Human endogenous retrovirus |
| 06/25/2008 | EP1171609B1 Lipoxygenase proteins and polynucleotides encoding the same |
| 06/25/2008 | EP1117687B1 Compositions and methods for wt1 specific immunotherapy |
| 06/25/2008 | EP1107789B1 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage |
| 06/25/2008 | EP1033996B1 Prevention and treatment of amyloidogenic disease |
| 06/25/2008 | EP0859625B1 Composition and methods for enhancing immune responses mediated by antigen-presenting cells |
| 06/25/2008 | EP0805859B2 A chemokine receptor able to bind to mcp-1, mip-1 alpha and/or rantes. |
| 06/25/2008 | CN101208356A Cancer specific PCNA isoform binding antibodies and uses thereof |
| 06/25/2008 | CN101205528A Spiro protomer strain and uses thereof |
| 06/25/2008 | CN101205255A Anti CD20 tetravalent antibody, preparation method and uses thereof |
| 06/25/2008 | CN101205254A Preparation of haliotis divericolor supertexta NF-kappa B antibody and detection method thereof |
| 06/25/2008 | CN101205253A Immune method for preparing antibody |
| 06/25/2008 | CN100397082C HCV-free-blood external preparing method |
| 06/25/2008 | CN100397081C Diagnosing tumorigenicity and determining resistance to the antineoplastic therapy |
| 06/25/2008 | CN100396784C Methods of inducing the expression of bone morphogenetic proteins (BMPs) and transforming growth factor-beta-proteins (TGF-ª‰s) in cells |
| 06/25/2008 | CN100396774C Immuno colloidal gold test paper strip for detecting sulfa drug residue |
| 06/25/2008 | CN100396699C Transgenic mammal carrying GANP gene transferred thereinto and utilization thereof |
| 06/25/2008 | CN100396698C New mastocancer related protein and its specificity multiclone antibody |
| 06/25/2008 | CN100396697C New mastocancer related protein and its specificity multiclone antibody |
| 06/24/2008 | US7392233 Image searching system, image searching method, and a recording medium storing an image searching program |
| 06/24/2008 | US7392141 Polypeptides; genetic engineering |
| 06/24/2008 | US7390888 Dendritic cell potentiation |
| 06/24/2008 | US7390887 Antibodies against PRO4330 |
| 06/24/2008 | US7390886 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumor and cell proliferative disorders |
| 06/24/2008 | US7390885 Humanized collagen antibodies and related methods |
| 06/24/2008 | US7390884 Lymphoid chemokines in the diagnosis, monitoring and treatment of inflammatory disease |
| 06/24/2008 | US7390883 PRO polypeptides; fusion proteins; immunoglobulins; cytokines; for stimulating release of tumor necrosis factor from blood; for modulating uptake of glucose by skeletal cells/adipocytes; for stimulating the release of proteoglycans from cartilage |
| 06/24/2008 | US7390882 Compositions and methods for the diagnosis and treatment of tumor |
| 06/24/2008 | US7390881 first component is the modified antigenic ectodomain of measles virus hemagglutinin protein, second component fused to first component that binds a surface protein of human immunodeficiency virus; for treating HIV infection and other therapeutic targets against which it is difficult to develop vaccines |
| 06/24/2008 | US7390878 PRO6090 polypeptides |
| 06/24/2008 | US7390877 Vectors with DNA encoding pro polypeptides |
| 06/24/2008 | US7390876 Identification and isolation of novel DNA and recombinant production of novel polypeptides |
| 06/24/2008 | US7390870 Immune-enhancing peptides |